Sun Life, the nation's leading independent stop-loss provider for self-funded employers, today released its 13th annual ...

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...

There were 22 secondary neoplasms. Types included leukemia/myelodysplastic syndrome (MDS; n = 15) and solid tumor (n = 7). Fine-Gray regression models examined for risk factors for leukemia/MDS and ...

Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.

Myeloproliferative neoplasms are a group of rare disorders of the bone marrow that cause an increase in the number of blood cells. You may also hear doctors call them MPN or myeloproliferative ...

Shares of Incyte (NASDAQ:INCY) climbed 7% today after the biopharmaceutical company announced that multiple presentations, including new late-breaking data for its monoclonal antibody INCA033989, have ...

Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care. In this video, John O.

Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203 The mammalian target of rapamycin (mTOR) inhibitor everolimus is US Food and Drug ...

It can be alarming to find a growth on your skin, but don’t worry. Most growths, known as skin neoplasms, are harmless. However, some can be cancerous or precancerous, so make sure you get them ...

There are six types of chronic myeloproliferative neoplasms, which vary based on whether the body is making too many red blood cells, white blood cells, or platelets. The bone marrow produces ...

Ischaemic heart disease remained the leading cause of death in the Philippines in 2024, according to the Philippine ...

Myeloproliferative neoplasms (MPNs) are a group of rare blood cancers in which the bone marrow produces an excess combination of white blood cells, red blood cells, and platelets. This ...